A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,513

Participants

Timeline

Start Date

May 31, 1996

Primary Completion Date

February 28, 2001

Study Completion Date

April 30, 2001

Conditions
Type 2 DiabetesNephropathy
Interventions
DRUG

MK0954, losartan / Duration of Treatment: mean 3.4 years

DRUG

Placebo / Duration of Treatment: mean 3.4 years

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00308347 - A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED) | Biotech Hunter | Biotech Hunter